UBS Raises Oracle Price Target to $285
UBS analyst Karl Keirstead raised the price target on Oracle (NYSE: ORCL) to $285.00 (from $250.00) while maintaining a Buy rating.
“Ahead of Oracle’s 4Q/May quarter presumably next week, we preview what we think are the key investor topics and likely FY27 commentary, as well as offer unvarnished feedback from four large customers and partners and one contractor with visibility into the big Abilene, TX, AI data center build-out.
Bottom line, we did not pick up evidence of any set-back in momentum and at 27x CY27 non-GAAP EPS, we remain Buy-rated on Oracle shares and constructive on the broader “long-hyperscaler” trade.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
